Knockout of interleukin-17A protects against sepsis-associated acute kidney injury
© The Author(s) 2016
Received: 24 January 2016
Accepted: 5 June 2016
Published: 22 June 2016
Sepsis-associated acute kidney injury (SA-AKI) is an independent risk factor for death in patients with sepsis, but treatment for it is limited. To improve the diagnosis and treatment of SA-AKI, we must first understand its pathogenesis. Recently, interleukin (IL)-17A has been shown to be associated with the pathogenesis of acute kidney injury and sepsis, but its role in SA-AKI remains unclear.
SA-AKI was induced in male C57BL/6 and IL-17A−/− mice using cecal ligation and puncture (CLP) operations for 24 h.
At 7 days, only seven mice survived in the wild-type septic group, but nine survived in the IL-17A−/− septic group, corresponding to survival rates of 25 % and 45 %, respectively. At 24 h after CLP operations, both wild-type and IL-17A−/− septic mice developed kidney injury. The IL-17A−/− septic mice exhibited decreased serum creatinine and blood urea nitrogen levels and an improved acute tubular necrosis score. The IL-17A−/− septic mice exhibited decreased IL-6, interferon-γ, tumor necrosis factor-α, CXCL1, CXCL2, and CXCL5 expression in kidney tissue, but increased IL-10 expression. In addition, renal neutrophil infiltration was attenuated significantly in the IL-17A−/− septic group. Moreover, IL-17A−/− septic mice showed significantly decreased apoptosis of tubular epithelial cells, including decreased TUNEL-positive tubular cell number and cleaved caspase-3 level, compared with the wild-type CLP group. Their Bax/Bcl-2 expression ratio was also increased.
Our study demonstrates that IL-17A knockout could protect against SA-AKI. We show that IL-17A plays a pathogenic role in SA-AKI by increasing the levels of proinflammatory cytokines and chemokines, and by inducing neutrophil infiltration and apoptosis of tubular epithelial cells. Accordingly, IL-17A may be a novel target in SA-AKI.
KeywordsIL-17A knockout Sepsis Sepsis-associated acute kidney injury
Sepsis-associated acute kidney injury (SA-AKI) is an independent risk factor for death in patients with sepsis , but its treatment is limited. To improve the diagnosis and treatment of SA-AKI, we must first understand its pathogenesis. In recent years, the majority of studies on this type of injury have focused on hemodynamic factors after bacterial invasion. However, in many patients, SA-AKI occurs without overt signs of global renal hypoperfusion and SA-AKI has been described in the presence of normal or even increased renal blood flow . Therefore, in recent years, apoptosis, neutrophil infiltration, and the production of proinflammatory cytokines have been considered important mechanisms of SA-AKI .
Interleukin (IL)-17 is a proinflammatory cytokine secreted mainly by TH17 cells and γδT cells . It constitutes a novel cytokine family that includes six structurally related isoforms, IL-17A to IL-17F . IL-17A, the first identified member of the IL-17 family, now synonymous with IL-17, acts on a variety of cells through its ubiquitous receptors. In addition, it induces the production of other cytokines and chemokines from a variety of cells and coordinates the recruitment of myeloid cells, such as monocytes and neutrophils, to sites of inflammation . The discovery of the IL-17A cytokine family provided a novel approach to examine the processes underlying inflammatory diseases. It can also help us to identify new therapeutic targets of inflammatory diseases.
Although all clinical research on neutralizing a single mediator of a single target was unsuccessful, the neutralization of IL-17A still showed promise. Studies have reported that IL-17A reached high levels in septic mice after cecal ligation and puncture (CLP) injury, and that the use of antibodies to neutralize IL-17A improved sepsis survival from 10 % to nearly 60 % . Accordingly, targeted IL-17A depletion has been adopted as a therapeutic strategy and is currently undergoing clinical trials for several human autoimmune diseases [8, 9].
Recently, IL-17A has also been shown to be associated with the pathogenesis of kidney and intestine ischemia/reperfusion (I/R) injury [10–12], but its role in SA-AKI remains unclear. Thus, in this study, we used IL-17A−/− mice to evaluate the role of IL-17A in an SA-AKI model induced by CLP injury.
Male C57BL/6 mice aged 8–10 weeks were purchased from the animal center at The Chinese People’s Liberation Army (PLA) General Hospital (Beijing, China). IL-17A−/− mice in a C57BL/6 background were kindly provided by Professor H. L. Wang (Shanghai Institute of Immunology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine). The mice were maintained on a chow diet in a 12-h light/12-h dark environment at 25 °C at The Chinese PLA General Hospital’s Animal Care Facility, in accordance with institutional guidelines. They were acclimated for 1 week prior to the experiments. All animal studies were approved by the Ethics Committee of The Chinese PLA General Hospital.
Mouse model of cecal ligation and puncture
Cecal ligation and puncture-induced sepsis was generated as described previously . Mice were anesthetized with 2 % pentobarbital, and a 1- to 2-cm midline incision was made along the linea alba of the abdominal muscle to isolate and exteriorize the cecum. A total of 75 % of the cecum was ligated with a 4-0 silk suture, and the cecum was punctured twice with a 21-gauge needle. A small amount (droplet) of feces was gently extruded from the holes to ensure patency. The cecum was then returned to the peritoneal cavity and the abdominal incision was closed with 4-0 silk sutures. After the operation, 1 mL of pre-warmed normal saline was administered into the peritoneal cavity. In the sham group, mice underwent the same procedure but were neither ligated nor punctured.
Wild-type and IL-17A−/− mice for blood tests and histological and immunochemical analyses were each divided into two groups: a sham group and a CLP group. Then euthanized 24 h after surgery. Wild-type and IL-17A−/− mice for survival study were also divided into two groups: a sham group and a CLP group. Then euthanized 7d after surgery (Additional file 1).
For a survival study, mice in each group were monitored closely for 7 days (n = 20/group), after which they were euthanized.
Assessment of kidney function
Kidney injury was assessed based on the levels of serum creatinine and blood urea nitrogen. Mouse serum samples were obtained at 24 h after CLP injury, and the serum was separated by centrifugation at 3000 rpm for 15 min at 4 °C and then stored at −20 °C until use.
For histopathological assessment, kidney tissues were harvested 24 h after CLP. Specimens were fixed in 10 % formaldehyde for at least 24 h. The samples were then embedded in paraffin and sectioned at 4-µm thickness for staining with periodic acid-Schiff. Stained sections were observed using a light microscope (Olympus IX71; Olympus, Tokyo, Japan) at a magnification of 400× and evaluated by three independent pathologists. Histological examinations for acute tubular necrosis were semi-quantified and blinded using the following scoring system, as described previously : 0 = none, 1 = ≤10 %; 2 = 11–25 %, 3 = 26–45 %, 4 = 46–75 %, and 5 = >75 %.
Primers used for real-time PCR
Forward primers (5′–3′)
Reverse primer (5′–3′)
Immunofluorescence studies of kidney samples
Neutrophil granulocyte infiltration into the kidney was evaluated by the detection of Ly6G-positive cells by immunofluorescence; Five-µm-thick kidney sections were cut and incubated overnight with rat anti-Ly6G (1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibody in a humidified chamber. Secondary antibodies conjugated to CY3 rabbit anti-rat immunoglobulin G (IgG; 1:50; Jackson ImmunoResearch Laboratories, West Grove, PA, USA) were applied for 1 h at room temperature in a darkened humidified chamber. Nuclei were stained with 4′,6-diamidino-2-phenylindole (Zhongshan Goldenbridge Biotechnology, Beijing, China). Each tissue section was observed in a blinded manner under a confocal laser scanning microscope (Olympus FluoView 1000) at a magnification of 600×.
For terminal deoxynucleotidyl-transferase-mediated dUTP nick-end labeling (TUNEL) staining, kidneys were fixed in 4 % paraformaldehyde, embedded in paraffin, and cut into 5-µm-thick sections and stained using the DeadEnd Fluorometric TUNEL system (Promega Corporation, Madison, WI, USA), in accordance with the manufacturer’s instructions, followed by visualization under an Olympus laser scanning confocal microscope (IX81). Quantitative analysis of TUNEL-positive cells was performed using the Image-Pro software in 20 random fields for each mouse by a technician who was blinded to the treatment groups. The mean of all counts was used for comparisons among the groups.
Western blot analysis
Kidney lysates were prepared by homogenization on ice for 30 min using radioimmunoprecipitation assay buffer [50 mM Tris–Cl (pH 7.6), 150 mM NaCl, 1 % NP-40, 0.1 % sodium dodecyl sulfate, 0.5 % deoxycholic acid, 1 μg/mL leupeptin, 1 μg/mL aprotinin, and 0.5 mM phenylmethylsulfonyl fluoride], and then centrifuged at 12,000 rpm for 30 min at 4 °C, after which supernatants were collected. A total of 100 μg of protein was separated by 15 % sodium dodecyl sulfate–polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. Anti-Bax, -Bcl-2, and -cleaved caspase-3 antibodies (Cell Signaling Technology, Danvers, MA, USA) were used as primary antibodies at 4 °C overnight, and horseradish peroxidase-conjugated anti-rabbit/mouse IgG (Santa Cruz Biotechnology) was used as the secondary antibody. Densitometry was performed using Quantity One software (Bio-Rad Laboratories, Hercules, CA, USA).
The survival of mice was estimated by Kaplan–Meier analysis. A log-rank test was used to analyze the survival data. Data are expressed as mean ± standard error. Differences were evaluated using unpaired Student’s t tests between two groups and one-way ANOVA for multiple comparisons, followed by a post hoc Student–Newman–Keuls test when necessary. The value of α was corrected by the number of comparisons [2α/n (n − 1)] to ensure α = 0.05 . mRNA levels were calculated using the 2−ΔΔCT method. Analyses were performed using SPSS for Windows (version 10.1; SPSS, Chicago, IL, USA). Statistical significance was set at P < 0.05.
Effect of IL-17A knockout on the survival of CLP-induced septic mice
Effects of IL-17A knockout on renal function in SA-AKI
Effects of IL-17A knockout on renal histology in SA-AKI
Effect of IL-17A knockout on renal cytokine and chemokine mRNA levels
The chemokines CXCL1, CXCL2, and CXCL5 are not only potent neutrophil chemoattractants but are also encoded by IL-17A target genes. We thus examined the mRNA levels of these chemokine genes related to IL-17A function in the kidney using RT-PCR. The CXCL1, CXCL2, and CXCL5 mRNA levels were increased significantly in the wild-type CLP group and decreased in the IL-17A−/− septic group (P < 0.05; Fig. 4). SA-AKI caused a significant increase in the mRNA levels of all five chemokines, consistent with increased neutrophil infiltration. Moreover, IL-17A knockout had the opposite effect on the expression of these chemokines after SA-AKI.
Effect of IL-17A knockout on neutrophil infiltration
Anti-apoptotic effects of IL-17A knockout in SA-AKI
In recent years, research has revealed that the main pathogenic factors in SA-AKI are not hemodynamic failure or ischemia, as previously thought, but inflammation and apoptosis . Accordingly, therapies aimed at suppressing apoptosis and inflammation are currently being sought.
In our study, we revealed that IL-17A knockout caused a marked amelioration of SA-AKI, which was associated with a reduction in neutrophil infiltration and tubular cell apoptosis. Moreover, IL-17A enhanced neutrophil infiltration, possibly by inducing CXC chemokine-mediated neutrophil migration. In light of these novel findings, IL-17A may become a new therapeutic target.
Increasing evidence has indicated that both adaptive and innate immunity play a role in the pathogenesis of sepsis . Notably, IL-17A acts as a bridge between adaptive and innate immunity through the inflammatory response , and thus occupies a unique position in the pathogenic process of sepsis. A growing body of evidence has also demonstrated that IL-17A is involved in the inflammatory response during kidney injury in acute renal obstruction . However, little was previously known about SA-AKI, although IL-17A is involved in the pathogenesis of sepsis. In this context, we previously reported the important finding that circulating IL-17A levels were elevated in SA-AKI . Therefore, we focused on the effect of IL-17A in SA-AKI using the IL-17A−/− CLP mouse model. Notably, in IL-17A−/− mice, kidney function and morphology were found to be protected after SA-AKI. In this study, genetic deficiency in IL-17A ameliorated SA-AKI markedly, as demonstrated by reduced mortality, improved inflammatory markers, and reduced neutrophil infiltration, which demonstrated a critical role for IL-17A in SA-AKI.
Neutrophil recruitment plays a major role in SA-AKI. Neutrophil chemotaxis and activation may be regulated by CXC chemokines. Interestingly, IL-17A has also been shown to induce the production of CXCL1, CXCL2, and CXCL5 in mouse osteoblastic cells and lung fibroblasts [21, 22]. Moreover, IL-17A has been shown to induce the recruitment of neutrophils into the airways via the production of CXC chemokines . However, the production of IL-17A during infection has not always been correlated with protection. In a murine CLP model of polymicrobial sepsis, IL-17A from γδT cells was detected, but its depletion led to a decrease in bacteremia and reductions in systemic proinflammatory cytokines (TNF-α, IL-1β, and IL-6) and chemokines . In our study, we found that the inhibition of IL-17A markedly decreased renal CXCL1, CXCL2, and CXCL5 expression and neutrophil infiltration. This is consistent with previous reports describing that elevated IL-17A induced neutrophil recruitment and increased inflammation in a more severe CLP model . IL-17A also enhanced cardiomyocyte LIX, KC, and MIP-2 production and neutrophil migration to the supernatant from conditioned cardiomyocytes in vitro . Although we have no further data to validate the pathogenic role of IL-17A in SA-AKI in vitro, which is a limitation of our study, our results still indicate that IL-17A may contribute to SA-AKI, at least in part through the regulation of neutrophil infiltration to the kidney by affecting CXC chemokine expression.
Apoptosis plays an important role in health and disease. It also contributes to kidney dysfunction in I/R or nephrotoxin-induced AKI [26, 27]. However, no consensus has been reached on the role of renal cell apoptosis in the development of SA-AKI. In terms of the histopathological findings from biopsies taken from septic AKI patients, these have been reported to include acute tubular injury or necrosis to varying degrees; leukocyte infiltration into glomeruli, interstitial capillaries, and tubular lumen; and apoptosis in tubular cells and on rare occasions in glomerular cells [28, 29]. In contrast, Langenberg et al.  reported a lack of any tubular injury or apoptosis in a sheep SA-AKI model. However, in our study, we observed that a substantial number of tubular cells underwent apoptosis. In addition to increased numbers of TUNEL-positive cells, cleaved caspase-3 activity and Bax were also increased in septic kidneys compared with those in sham kidneys. Meanwhile, the reduced level of the anti-apoptosis protein Bcl-2 also suggested that apoptosis occurred in the kidneys of septic mice after CLP surgery. IL-17A has also been shown to induce apoptosis of vascular smooth muscle cells and airway epithelial cells [31, 32]. However, there are no reports on the role of IL-17A in renal tubular cell apoptosis. Our in vivo study showed that IL-17A knockout reduced tubular cell apoptosis, as confirmed by the decreased number of TUNEL-positive tubular cells, the reduced cleaved caspase-3 activity, and the ratio of pro-apoptotic (Bax) to anti-apoptotic (Bcl-2) proteins. IL-17A may trigger apoptosis directly in tubular cells or indirectly by mediating the production of other factors. However, the regulation of cleaved caspase-3 activity and the Bax/Bcl-2 ratio demonstrated that IL-17A activated intrinsic signaling pathways. These findings indicate that IL-17A plays a pathogenic role in SA-AKI by inducing apoptosis and neutrophil infiltration (Additional file 1).
There are some limitations to this study. A previous study reported that SA-AKI does not result from hypoperfusion alone, but may arise to a large extent from renal inflammation and tubular responses to various sepsis mediators. In many patients, SA-AKI occurs without overt signs of global renal hypoperfusion and SA-AKI has been described in the presence of normal or even increased renal blood flow . Therefore, in our study, we did not perform hemodynamic monitoring, which was one of the limitations. Another previous study also reported that the neutralization of peritoneal IL-17A markedly improves lung injury in severe CLP-induced septic mice . Although we did not prove a beneficial effect of blocking IL-17A in other organ systems in this study, based on the above data, we believe that the beneficial effect of blocking IL-17A could be mediated by other organ systems as well as AKI. Moreover, although we observed decreased levels of IL-17A-related cytokines and chemokines in renal tissues after IL-17A knockout, the mechanism by which IL-17A knockout could protect against SA-AKI remains unclear. It is also needs to be determined whether the improved renal apoptosis is directly related to the knockout of IL-17A.
Overall, our study demonstrated that IL-17A knockout could protect against SA-AKI. We showed that IL-17A may play a pathogenic role in SA-AKI by increasing the levels of proinflammatory cytokines and chemokines, and reducing neutrophil infiltration and apoptosis of tubular epithelial cells. Accordingly, IL-17A may be a novel target in the treatment of SA-AKI.
acute kidney injury
cecal ligation and puncture
sepsis-associated acute kidney injury
one-way analysis of variance
LCJ, CXM, and ZL generated the hypothesis; LCJ, CXM, ZL, CGY, and MK participated in study design and coordination; LCJ, FZ, XY, SXF, and FB performed the experiments; LCJ subjected the mice to behavioral tasks during the experimental period; LF and LCJ performed the statistical analysis; LCJ and LF wrote the manuscript; and CXM and ZL made critical revisions to the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
This research was supported by a Grant from the Fund of Chinese PLA 12th Five-Year Plan for Medical Sciences (BWS11J027), National Natural Science Foundation of China (81170643, 81170688, 81470973).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53:961–73.View ArticlePubMedPubMed CentralGoogle Scholar
- Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S. Renal blood flow in sepsis. Crit Care. 2005;9:R363–74.View ArticlePubMedPubMed CentralGoogle Scholar
- Wan L, Bagshaw SM, Langenberg C, Langenberg C, Saotome T, May C, Bellomo R. Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med. 2008;36(Suppl 4):S198–203.View ArticlePubMedGoogle Scholar
- Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007;25:821–52.View ArticlePubMedGoogle Scholar
- Chong DL, Ingram RJ, Lowther DE, Muir R, Sriskandan S, Altmann DM. The nature of innate and adaptive interleukin-17A responses in sham or bacterial inoculation. Immunology. 2012;136:325–33.View ArticlePubMedPubMed CentralGoogle Scholar
- Ley K, Smith E, Stark MA. IL-17A-producing neutrophil-regulatory Tn lymphocytes. Immunol Res. 2006;34:229–42.View ArticlePubMedGoogle Scholar
- Li J, Zhang Y, Lou J, Zhu J, He M, Deng X, et al. Neutralisation of peritoneal IL-17A markedly improves the prognosis of severe septic mice by decreasing neutrophil infiltration and proinflammatory cytokines. PLoS One. 2012;7:e46506.View ArticlePubMedPubMed CentralGoogle Scholar
- Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med. 2010;2:52–72.View ArticleGoogle Scholar
- Genovese MC, Van den Bosch F, Roberson SA, Bojin S, Biagini IM, Ryan P, et al. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum. 2010;62:929–39.View ArticlePubMedGoogle Scholar
- Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med. 2009;15:946–50.View ArticlePubMedGoogle Scholar
- Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, et al. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest. 2010;120:331–42.View ArticlePubMedGoogle Scholar
- Edgerton C, Crispin JC, Moratz CM, Bettelli E, Oukka M, Simovic M, et al. IL-17 producing CD4 T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. Clin Immunol. 2009;130:313–21.View ArticlePubMedGoogle Scholar
- Hubbard WJ, Choudhry MA, Schwacha MG, Rue LW 3rd, Bland KI, Chaudry IH, et al. Cecal ligation and puncture. Shock. 2005;24(Suppl 1):52–7.View ArticlePubMedGoogle Scholar
- Lien YH, Yong KC, Cho C, Igarashi S, Lai LW. S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int. 2006;69:1601–8.View ArticlePubMedGoogle Scholar
- Hu J, Zhang L, Wang N, Ding R, Cui S, Zhu F, et al. Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions. Kidney Int. 2013;84:521–31.View ArticlePubMedPubMed CentralGoogle Scholar
- Gonçalves GM, Zamboni DS, Câmara NO. The role of innate immunity in septic acute kidney injuries. Shock. 2010;34(Suppl 1):22–6.View ArticlePubMedGoogle Scholar
- Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis of sepsis. Annu Rev Pathol. 2011;6:19–48.View ArticlePubMedPubMed CentralGoogle Scholar
- Ma AI. The ubiquitous nature of IL-17. Nat Immunol. 2012;13:1034–5.View ArticlePubMedGoogle Scholar
- Dong X, Bachman LA, Miller MN, Nath KA, Griffin MD. Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction. Kidney Int. 2008;74:1294–309.View ArticlePubMedPubMed CentralGoogle Scholar
- Luo CJ, Zhang FJ, Zhang L, Feng Z, Sun XF, Chen XM, et al. Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice. Shock. 2014;41:123–9.View ArticlePubMedGoogle Scholar
- Ruddy MJ, Shen F, Smith JB, Sharma A, Gaffen SL. Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol. 2004;76:135–44.View ArticlePubMedGoogle Scholar
- Zhou X, Chen Q, Moore J, Kolls JK, Halperin S, Wang J. Critical role of the interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species. Infect Immun. 2009;77:5059–70.View ArticlePubMedPubMed CentralGoogle Scholar
- Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, Skoogh BE, Linden A. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999;162:2347.PubMedGoogle Scholar
- Flierl MA, Rittirsch D, Gao H, et al. Adverse functions of IL-17A in experimental sepsis. FASEB J. 2008;22:2198–205.View ArticlePubMedGoogle Scholar
- Liao YH, Xia N, Zhou SF, Tang TT, Yan XX, Lv BJ, et al. Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil Infiltration. J Am Coll Cardiol. 2012;59:420–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Terada Y, Inoshita S, Kuwana H, Kobayashi T, Okado T, Ichijo H, et al. Important role of apoptosis signal-regulating kinase1 in ischemic acute kidney injury. Biochem Biophys Res Commun. 2007;364:1043–9.View ArticlePubMedGoogle Scholar
- Kindt N, Menzebach A, Van de Wouwer M, Betz I, De Vriese A, Conway EM. Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure. FASEB J. 2008;22:510–21.View ArticlePubMedGoogle Scholar
- Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM. Apoptotic cell death in patients with sepsis, shock and multiple organ dysfunction. Crit Care Med. 1999;27:1230–51.View ArticlePubMedGoogle Scholar
- Lerolle N, Nochy D, Guérot E. Histopathology of septic shock induced renal injury: apotosis and leukocytic infiltration. Intensive Care Med. 2010;36:471–8.View ArticlePubMedGoogle Scholar
- Langenberg C, Gobe G, Hood S, May CN, Bellomo R. Renal histopathology during experimental septic acute kidney injury and recovery. Crit Care Med. 2014;42:e58–67.View ArticlePubMedGoogle Scholar
- Erbel C, Chen L, Bea F, Wangler S, Celik S, Lasitschka F, et al. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol. 2009;183:8167–75.View ArticlePubMedGoogle Scholar
- Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA, Artis D. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med. 2010;207:1293–305.View ArticlePubMedPubMed CentralGoogle Scholar
- Honore PM, Jacobs R, Hendrickx I, Bagshaw SM, Joannes-Boyau O, Boer W, et al. Prevention and treatment of sepsis-induced acute kidney injury: an update. Ann Intensive Care. 2015;5:51.View ArticlePubMedPubMed CentralGoogle Scholar